1-10 of 10
David Bearss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B84: HCI-2528 is a potent inhibitor of LSD1 with improved druglike characteristics.

Bret J. Stephens, Venkataswamy Sorna, Emily Theisen, Hariprasad Vankayalapati, Steven Warner, David Bearss, Sunil Sharma
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B84.
https://doi.org/10.1158/1535-7163.TARG-11-B84
Published: 12 November 2011
View article titled, Abstract B84: HCI-2528 is a potent inhibitor of LSD1 with improved druglike characteristics.
Journal Articles

Abstract C199: Development of potent, small‐molecule inhibitors of ETK

David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Chongtie Shi, Chunlin Tang, Eric Gourley, Xiao‐Hui Liu, William Hewitt, Hariprasad Vankayalapati, Steven Warner, Colin Olsen, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C199.
https://doi.org/10.1158/1535-7163.TARG-09-C199
Published: 10 December 2009
View article titled, Abstract C199: Development of potent, small‐molecule inhibitors of ETK
Journal Articles

Abstract B272: The novel PIM kinase inhibitor SGI‐1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma

Devalingam Mahalingam, Ernest Medina, Ronan T. Swords, Kevin R. Kelly, David Bearss, Gavin Choy, Pietro Taverna, Jennifer S. Carew, Francis J. Giles, Steffan T. Nawrocki
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B272.
https://doi.org/10.1158/1535-7163.TARG-09-B272
Published: 10 December 2009
View article titled, Abstract B272: The novel PIM kinase inhibitor SGI‐1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma
Journal Articles

Abstract C206: In vivo activity of SGI‐1252, a potent, small‐molecule dual inhibitor of JAK2 and ALK2

Vollmer David, Jared Bearss, Carissa Jones, Virgil McCarthy, Eric Gourley, Xiao‐Hui Liu, Hariprasad Vankayalapati, Steven Warner, Colin Olsen, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C206.
https://doi.org/10.1158/1535-7163.TARG-09-C206
Published: 10 December 2009
View article titled, Abstract C206: <em>In vivo</em> activity of SGI‐1252, a potent, small‐molecule dual inhibitor of JAK2 and ALK2
Journal Articles

Abstract A190: In vivo activity of SGI‐110, a novel hypomethylating agent for treatment in hematology and solid malignancies

Jason Scholl, David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Paul Severson, Sanjeev Redkar, Rajashree Joshi‐Hangal, Roger Inloes, Chongtie Shi, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A190.
https://doi.org/10.1158/1535-7163.TARG-09-A190
Published: 10 December 2009
View article titled, Abstract A190: <em>In vivo</em> activity of SGI‐110, a novel hypomethylating agent for treatment in hematology and solid malignancies
Journal Articles

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge, David Bearss, Gregory Berk, Sarath Kanekal, Sanjeev Redkar, Pietro Taverna, David B. Agus, Anjali Jain
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2882–2893.
https://doi.org/10.1158/1535-7163.MCT-09-0293
Published: 12 October 2009
View article titled, Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
Open the PDF for Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes in another window
Journal Articles

MP470 suppresses repair of double-strand breaks following treatment with DNA-damaging agents.

Cory Grand, Vatsala Naageshwaran, Jeremy Lamb, Paul Severson, Hariprasad Vankayalapati, Steven Warner, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A173.
Published: 01 November 2007
View article titled, MP470 suppresses repair of double-strand breaks following treatment with DNA-damaging agents.
Journal Articles

The decitabine-derived demethylating dinucleotide, S110 shows improved activity due to increased drug delivery and stability

Steven Warner, Adrianne Clifford, Krzysztof Swierczek, Hariprasad Vankayalapati, Paul Severson, Jared Bearss, Jeremy Lamb, Donald Lavelle, Kestis Vaitkus, Joseph DiSimone, Chunlin Tang, Sanjeev Redkar, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B140.
Published: 01 November 2007
View article titled, The decitabine-derived demethylating dinucleotide, S110 shows improved activity due to increased drug delivery and stability
Journal Articles

A small molecule inhibitor of Pim-1 kinase with activity in both hematological and solid tumor malignancies

Jeremy Lamb, Eric Gourley, Xiao-Hui Liu, Cory Grand, Hariprasad Vankayalapati, Steven Warner, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C208.
Published: 01 November 2007
View article titled, A small molecule inhibitor of Pim-1 kinase with activity in both hematological and solid tumor malignancies
Journal Articles

Effect of small molecule inhibitors of JAK2 kinase on modulating signaling cascades downstream of cytokine receptors

Colin Olsen, Eric Gourley, Xiao-Hui Liu, Jeff Walker, Cory Grand, Steven Warner, Hariprasad Vankayalapati, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C200.
Published: 01 November 2007
View article titled, Effect of small molecule inhibitors of JAK2 kinase on modulating signaling cascades downstream of cytokine receptors